drugset / Trial / NCT01044836
Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male Volunteers
RandomizedCrossoverQuadruple-blindBasic science
Summary
The purpose of this study is compare the safety and pharmacokinetic characteristics of HD203 with those of etanercept after subcutaneous injection in healthy male volunteers.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-07
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HD203 | Unknown | 25 mg | Subcutaneous |
Indications
No indication recorded.